1. Home
  2. MC vs MMED Comparison

MC vs MMED Comparison

Compare MC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$66.71

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$11.82

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MC
MMED
Founded
2007
1983
Country
United States
United States
Employees
1416
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.1B
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
MC
MMED
Price
$66.71
$11.82
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$72.88
$22.56
AVG Volume (30 Days)
823.8K
577.4K
Earning Date
04-29-2026
06-03-2026
Dividend Yield
3.88%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
N/A
N/A
Revenue This Year
$18.28
$15.99
Revenue Next Year
$17.22
$10.00
P/E Ratio
$89.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$51.06
$10.65
52 Week High
$78.22
$17.86

Technical Indicators

Market Signals
Indicator
MC
MMED
Relative Strength Index (RSI) 60.01 48.16
Support Level $61.62 $10.65
Resistance Level $72.54 $12.19
Average True Range (ATR) 2.00 0.74
MACD 0.19 0.15
Stochastic Oscillator 80.03 76.62

Price Performance

Historical Comparison
MC
MMED

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Share on Social Networks: